Navigation Links
ThromboGenics and BioInvent Announce Publication of Exciting Data on a Novel Class of Angiogenesis Inhibitors in Cell
Date:11/1/2007

LEUVEN, Belgium and LUND, Sweden, November 2 /PRNewswire/ --

- Novel Anti-PlGF Antibody, TB-403, Being Developed by ThromboGenics and BioInvent for Cancer Expected to Enter the Clinic Later This Year

ThromboGenics NV (Euronext Brussels: THR), a biotechnology company focused on vascular disease, and co-development partner, BioInvent International (Nordic Exchange: BINV), announce today the publication of data in Cell(1) that highlight for the first time the therapeutic potential of anti-PlGF agents to treat cancer based on research performed at the University of Leuven, Belgium and the Flanders Institute for Biotechnology (VIB). The data published in Cell show that antibodies against PlGF (placental growth factor) can inhibit cancer tumour growth and the development of metastases in preclinical models, without affecting healthy tissues. These attractive properties are due to PIGF inhibitors acting by blocking the formation of new blood vessels only in the cancer tissue.

ThromboGenics and BioInvent have made the decision to advance their lead anti-PIGF monoclonal antibody, TB-403, into the clinic, and expect to start the first Phase I clinical trial by the end of 2007.

In particular, preclinical data showed that anti-PlGF antibodies could:

- Inhibit tumour growth and the development occurrence of tumour metastases

- Inhibit tumour growth with a distinct but complementary mechanism to currently available anti-angiogenic therapy

- Not induce resistance because it does not evoke an "angiogenic rescue" by the tumour, in contrast to current angiogenesis inhibitors

- Enhance the sensitivity of tumours to anti-VEGF

- Amplify anti-tumour effect of chemotherapy

- Not cause or aggravate the typical side effects of anti-angiogenic antibodies when given as combination therapy.

Therefore, anti-PlGF antibodies, such as TB-403, potentially have an improved efficacy/toxicity profile that would be expected to inh
'/>"/>

SOURCE ThromboGenics NV
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related biology technology :

1. Speaker announces business members of IT Task Force
2. Doyle announces technology tax credits for Berbee
3. Doyle announces new energy, global warming policies
4. Doyle, WARF announce partnership to lure stem cell companies
5. Doyle announces $80M renewable energy strategy
6. GE announces first installation of Discovery VCT
7. UWM announces winners of RGI awards
8. Third Wave announces two senior management appointments
9. Mirus announces new method for making antibodies
10. Merge announces sofware updates, upcoming acquisition
11. Small Tree announces ethernet solution for Apple Xserv G5
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/24/2013)... This market report summarizes the ... carried out in May 2013. The full report ... the responses for each question, its segmentation and ... highlights some interesting differences, particularly between Pharma, Biotech ... were developed to estimate the in house and ...
(Date:5/24/2013)... Toronto, Canada (PRWEB) May 24, 2013 ... selective barriers, and uptake or efflux transporters at the ... may be related to unbound fractions in the tissue ... understanding of these disposition challenges is required to guide ... and to identify any species-dependent variables that may impact ...
(Date:5/24/2013)... May 24, 2013 The Oklahoma tornado ... following its ravage, the mayor of Moore, one of the ... houses, said a report from cnn.com. Reaching out to also ... complimentary Molderizer and Safe Shield to counter the looming mold ... published on May 22, 2013, caused 24 deaths, My Cleaning ...
(Date:5/24/2013)... 2013 Vestiage, Inc. (stock symbol ... on science-based research and development, sales and marketing ... nutraceuticals, announced today that it is awarding exclusive ... sale of Reluma Skin Illuminating Facial Care. Qualified ... by sending an email to info(at)vestiageinc(dot)com and putting ...
Breaking Biology Technology:Kinase Market Profiling - In House & Outsourced Trends 2015 Forecast in New Research Report at ReportsnReports.com 2Kinase Market Profiling - In House & Outsourced Trends 2015 Forecast in New Research Report at ReportsnReports.com 3Kinase Market Profiling - In House & Outsourced Trends 2015 Forecast in New Research Report at ReportsnReports.com 4DMPK for Targeted Tissue Delivery: Solutions for the Most Challenging Part of Outsourcing, New Life Science Webinar Hosted by Xtalks 2Mayor of Oklahoma-Tornado-Impaired Town Proposes Storm Shelter Bill, My Cleaning Products Offers Complimentary Molderizer and Safe Shield to Help Victim with Looming Mold 2Vestiage Announces Launch of Exclusive Territories for Reluma Brand Sales in USA 2Vestiage Announces Launch of Exclusive Territories for Reluma Brand Sales in USA 3Vestiage Announces Launch of Exclusive Territories for Reluma Brand Sales in USA 4Vestiage Announces Launch of Exclusive Territories for Reluma Brand Sales in USA 5
... adept at climbing through difficult terrain using an intricate adhesive ... how they switch on their unique system of traction. ... South Carolina have discovered that the geckos, amazing grip is ... adhesive research will be published Wed., Aug. 5, at 00:001 ...
... , , SOUTH SAN ... PARD ), a biopharmaceutical company focused on oncology, today reported financial ... a corporate update. , , "During the ... 2 picoplatin data from our colorectal and prostate cancer programs. ...
... NEW YORK, Aug. 4 Keryx Biopharmaceuticals, Inc. (Nasdaq: KERX ... 8:30 a.m. EDT to discuss the second quarter 2009 financial results and ... Officer of the Company, will host the call. Keryx will announce ... issued prior to the call. , , In order ...
Cached Biology Technology:New angle on gecko research 2Poniard Pharmaceuticals Reports Second Quarter 2009 Financial Results and Provides a Corporate Update 2Poniard Pharmaceuticals Reports Second Quarter 2009 Financial Results and Provides a Corporate Update 3Poniard Pharmaceuticals Reports Second Quarter 2009 Financial Results and Provides a Corporate Update 4Poniard Pharmaceuticals Reports Second Quarter 2009 Financial Results and Provides a Corporate Update 5Poniard Pharmaceuticals Reports Second Quarter 2009 Financial Results and Provides a Corporate Update 6Poniard Pharmaceuticals Reports Second Quarter 2009 Financial Results and Provides a Corporate Update 7Poniard Pharmaceuticals Reports Second Quarter 2009 Financial Results and Provides a Corporate Update 8Keryx Biopharmaceuticals, Inc. to Hold Conference Call on Second Quarter 2009 Financial Results on Thursday, August 6, 2009 at 8:30am EDT 2
(Date:5/23/2013)... , Automated conserved noncoding sequence (CNS) discovery reveals ... , Within the genome of each species, there ... change in position and sequence over millions of years, ... these evolutionarily stable sequences, so-called conserved noncoding sequences (CNSs), ... or the condensation of chromosomes, but the function of ...
(Date:5/23/2013)... said to be the world,s most popular fruit, can ... research with purple GM varieties. , "Working with ... by the addition of a specific compound, allows us ... said Professor Cathie Martin from the John Innes Centre. ... with better flavour, health and shelf life characteristics because ...
(Date:5/23/2013)... Pacific Northwest National Laboratory honored more than ... of intellectual property at PNNL,s annual Intellectual Property ... The Department of Energy national laboratory named materials ... his work developing battery materials that can store ... electrical grid, and reduce the time it takes ...
Breaking Biology News(10 mins):Frontiers news briefs: May 23 2Frontiers news briefs: May 23 3The world's favorite fruit only better-tasting and longer-lasting 2PNNL staff recognized for scientific accomplishments, moving technologies into the marketplace 2
... at the University of Georgia have developed a "super ... pretreated pine -- one of the most common species ... could help biofuels replace gasoline as a transportation fuel. ... biomass such as pine, but it is a notoriously ...
... of small rodents throwing themselves off the top of cliffs ... longer be determined by hearsay as a new report suggests ... climate. The study, published today, 18 November, in IOP ... may be maintaining the biomass of certain plants in the ...
... The Seventh Annual Symposium on Predictive Health, to be ... health and the human microbiome. The human microbiome consists ... viruses, which reside throughout the body. Study of ... across the United States, including a major federal initiative ...
Cached Biology News:UGA researchers develop 'super' yeast that turns pine into ethanol 2Could lemmings be involved in regulating our climate? 2Predictive health symposium will focus on human microbiome 2
... The Xcise is a powerful technology ... throughput proteome analysis. High quality sample ... untrained user. , The Xcise is a ... for high throughput proteome analysis. It combines ...
Extra Large bottle for hybridization 300 x 70mm...
Request Info...
... Thermo IEC Microtube Rotor is TWO ROTORS ... change rotors. You can spin both ... tubes. Exclusive polypropylene rotor design provides excellent ... Polypropylene rotors are fully compatible with ...
Biology Products: